Newhouse says its possible people may be prescribed GLP-1s to lower the risk of Alzheimers disease in the future
This structural tweak is what gives it stronger, faster, and more localized effects compared to standard IGF-1
Reduced oxidative stress might slow brain aging and could theoretically reduce the risk of neurodegenerative conditions like Alzheimers
Common ones include nausea, fatigue, dizziness, diarrhea, constipation, and headache
fMRI data also showed altered activation in brain regions tied to food reward and cravings (insula, putamen, orbitofrontal cortex)
In vivo, this may be due to the fact that amlodipine is characterized by a long half-life (3550 h) and a long duration of action 17